Results 131 to 140 of about 19,427 (285)

Sickle Cell Disease: Historical Overview and Current Therapies

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Sickle cell disease (SCD) affects millions worldwide, yet the limited treatment options currently available do not always adequately control the disease and carry significant side effects. At present, the only curative treatment is hematopoietic stem cell (HSC) transplantation, a procedure that carries considerable challenges and numerous ...
Oluwaseun O. Babatunde   +4 more
wiley   +1 more source

The revocation of the will

open access: yes
reservedL'elaborato è incentrato sulla revoca delle disposizioni testamentarie. Inizialmente, all'interno del primo capitolo, verrà trattata in generale la vocazione testamentaria ( caratteristiche del testamento, elementi essenziali ed accidentali ed ...
GALIAZZO, IRENE
core  

Enhanced Certificate Revocation

open access: yes, 1996
We apply off-line/on-line signatures to provide an alternative solution to the problem of certificate revocation. The new systems dismiss with traditional CRLs (Certificate Revocation Lists) and yield public-key infrastructures that are substantially ...
Micali, Silvio
core  

A green solvent processable, self‐doped N‐annulated perylene butyl tetraester applied as a solar cell cathode interlayer

open access: yesPolymer International, EarlyView.
A new organic molecular cathode interlayer is presented built upon the perylene butyl tetraester scaffold. The new molecule incorporates N‐annulation and a functional amine group to control optical, electrochemical and physical properties and delivers excellent solar cell performance. Abstract We report a new amino‐bay‐substituted, N‐annulated perylene
Kathryn M Wolfe   +7 more
wiley   +1 more source

The first RNAi‐based biopesticide approved in the United States: regulatory implications for the European Union – the case of Ledprona (Calantha™)

open access: yesPest Management Science, EarlyView.
The approval of the RNA interference‐based biopesticide Ledprona (Calantha™) in the USA marks a milestone for RNA‐based crop protection. We discuss the regulatory implications for the European Union, highlighting opportunities, challenges, and the need for adapted risk assessment frameworks for RNA‐based plant protection products.
Aline Koch, Gabi Krczal
wiley   +1 more source

Industry 5.0 for Sustainable Healthcare Services: Analyzing the Prospects and Obstacles for the Indian Healthcare System

open access: yesSustainable Development, EarlyView.
ABSTRACT The fifth industrial revolution (I5.0), which is based on the utilization of interconnected data for efficient resource usage in meeting human requirements, proposes efficient solutions to resource constraint situations. However, the transition to I5.0 in the health sector is not easy and has to face several obstacles.
Ajay Jha   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy